Process for the Preparation of Compounds useful as inhibitors of SGLT

摘要

The present invention is directed to a novel process for the preparation of compounds of Formula I having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.
wherein Ring A and Ring B are one of the following:
(1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; or
(2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, or an optionally substituted unsaturated fused heterobicyclic ring wherein Y is linked to the heterocyclic ring of the fused heterobicyclic ring; or
(3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, wherein the sugar moiety X-(sugar) and the moiety -Y-(Ring B) are both on the same heterocyclic ring of the fused heterobicyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring;
X is a carbon atom;
Y is -(CH 2 ) n -; wherein n is 1 or 2;
provided that in Ring A, X is part of an unsaturated bond;
or a pharmaceutically acceptable salt or solvate thereof.